메뉴 건너뛰기




Volumn 15, Issue 6, 2008, Pages 1800-1801

Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN C;

EID: 43449097232     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9785-x     Document Type: Letter
Times cited : (5)

References (7)
  • 1
    • 34548557240 scopus 로고    scopus 로고
    • Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity
    • Kusamura S, Baratti D, Younan R, et al. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol 2007;14:2550-8
    • (2007) Ann Surg Oncol , vol.14 , pp. 2550-8
    • Kusamura, S.1    Baratti, D.2    Younan, R.3
  • 2
    • 0030909491 scopus 로고    scopus 로고
    • Pharmacokinetic problems in peritoneal drug administration: Tissue penetration and surface exposure
    • Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst 1997;89:480-7
    • (1997) J Natl Cancer Inst , vol.89 , pp. 480-7
    • Dedrick, R.L.1    Flessner, M.F.2
  • 3
    • 33645647666 scopus 로고    scopus 로고
    • Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
    • Sugarbaker PH, Stuart OA, Carmignani CP. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C. Cancer Chemother Pharmacol 2006;57:703-8
    • (2006) Cancer Chemother Pharmacol , vol.57 , pp. 703-8
    • Sugarbaker, P.H.1    Stuart, O.A.2    Carmignani, C.P.3
  • 4
    • 0041743197 scopus 로고    scopus 로고
    • Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis
    • Elias DM, Sideris L. Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. Surg Oncol Clin N Am 2003;12:755-69
    • (2003) Surg Oncol Clin N Am , vol.12 , pp. 755-69
    • Elias, D.M.1    Sideris, L.2
  • 5
    • 0042878580 scopus 로고    scopus 로고
    • Extent of a parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
    • de Lima Vazquez V, Stuart OA, Sugarbaker PH. Extent of a parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Pharmacol 2003;52:108-12
    • (2003) Cancer Chemother Pharmacol , vol.52 , pp. 108-12
    • De Lima Vazquez, V.1    Stuart, O.A.2    Sugarbaker, P.H.3
  • 6
    • 34547433042 scopus 로고    scopus 로고
    • Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer
    • Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol 2007;14:2281-8
    • (2007) Ann Surg Oncol , vol.14 , pp. 2281-8
    • Bijelic, L.1    Yan, T.D.2    Sugarbaker, P.H.3
  • 7
    • 34547399955 scopus 로고    scopus 로고
    • Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms
    • Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 2007;14:2289-99
    • (2007) Ann Surg Oncol , vol.14 , pp. 2289-99
    • Yan, T.D.1    Bijelic, L.2    Sugarbaker, P.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.